We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
-8.26%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.47B
AUM Growth
-$1.7B
(-54%)
Cap. Flow
-$1.51B
Cap. Flow
% of AUM
-102.85%
Top 10 Holdings %
Top 10 Hldgs %
50.92%
Holding
53
New
9
Increased
13
Reduced
10
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$123M |
| 2 |
AET
Aetna Inc
AET
|
+$83M |
| 3 |
Centene
CNC
|
+$53.8M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$52M |
| 5 |
MGM Resorts International
MGM
|
+$34.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$65.3M |
| 2 |
AGN
Allergan plc
AGN
|
+$62.9M |
| 3 |
OPLN
Openlane
OPLN
|
+$55.2M |
| 4 |
Cigna
CI
|
+$54.5M |
| 5 |
Zoetis
ZTS
|
+$54.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.08% |
| 2 | Financials | 9.75% |
| 3 | Communication Services | 7.48% |
| 4 | Consumer Discretionary | 6.93% |
| 5 | Consumer Staples | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$40.9B
| $108M | 7.33% |
+1,904,346
| New | +$123M |
|
|
MDCO
2
DELISTED
Medicines Co
MDCO
| $93.6M | 6.39% |
2,466,205
-24,806
| -1% | -$871K |
|
3
Post Holdings
POST
$4.15B
| $85.6M | 5.84% |
2,214,141
-332,447
| -13% | -$13.1M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $78.6M | 5.36% |
+718,401
| New | +$83M |
|
5
UnitedHealth
UNH
$381B
| $73.5M | 5.01% |
633,535
+163,790
| +35% | +$19.6M |
|
|
6
MGM Resorts International
MGM
$11.4B
| $65.4M | 4.46% |
3,547,076
+1,720,422
| +94% | +$34.4M |
|
7
Labcorp
LH
$25.5B
| $64.8M | 4.42% |
695,475
-61,012
| -8% | -$6.31M |
|
|
8
Centene
CNC
$30.7B
| $63.8M | 4.35% |
2,351,102
+1,606,906
| +216% | +$53.8M |
|
9
Alnylam Pharmaceuticals
ALNY
$27.1B
| $57.2M | 3.9% |
712,389
+88,509
| +14% | +$9.83M |
|
10
HCA Healthcare
HCA
$86.9B
| $56.5M | 3.85% |
729,813
-69,598
| -9% | -$6.16M |
|
11
Insulet
PODD
$11.5B
| $56.1M | 3.83% |
2,165,850
+360,669
| +20% | +$10.9M |
|
|
WCG
12
DELISTED
Wellcare Health Plans, Inc.
WCG
| $54.9M | 3.75% |
637,428
+228,272
| +56% | +$20M |
|
13
Ironwood Pharmaceuticals
IRWD
$690M
| $49.5M | 3.37% |
5,670,039
+2,673,036
| +89% | +$24.9M |
|
|
KYTH
14
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $48.1M | 3.28% |
641,036
| – | – |
|
15
Charter Communications
CHTR
$17.4B
| $44.6M | 3.04% |
253,822
| – | – |
|
|
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
| $43.8M | 2.99% |
+2,083,679
| New | +$52M |
|
17
VeriSign
VRSN
$26.1B
| $43.4M | 2.96% |
615,494
| – | – |
|
18
Meta Platforms (Facebook)
META
$1.4T
| $42.6M | 2.91% |
474,409
-100,591
| -17% | -$9.23M |
|
19
Assured Guaranty
AGO
$3.69B
| $35.9M | 2.45% |
1,437,876
-912,124
| -39% | -$22.9M |
|
|
LNW
20
DELISTED
Light & Wonder
LNW
| $31.6M | 2.15% |
3,020,580
-592,662
| -16% | -$7.77M |
|
21
TG Therapeutics
TGTX
$8.01B
| $30.8M | 2.1% |
3,053,916
+1,516,387
| +99% | +$22.6M |
|
22
PennyMac Financial
PFSI
$3.91B
| $28.4M | 1.94% |
1,776,073
-50,887
| -3% | -$883K |
|
|
EXAS
23
DELISTED
Exact Sciences
EXAS
| $27.7M | 1.89% |
1,540,841
| – | – |
|
24
Atara Biotherapeutics
ATRA
$74.4M
| $23.1M | 1.57% |
29,377
+9,325
| +47% | +$11.4M |
|
25
Boise Cascade
BCC
$2.67B
| $22.8M | 1.56% |
904,341
-776,331
| -46% | -$24.8M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2015 Portfolio in Review
As of Q3 2015, Bridger Management held 53 positions worth $1.47B, down 54% from $3.16B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Bridger Management withdrew a net $1.51B in Q3 2015, closing 16 positions and reducing 10 holdings. Its most notable exit was Cardinal Health, an estimated $65.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 29% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Bridger Management opened a new position in Teva Pharmaceuticals worth $108M.
- Bridger Management's largest Q3 2015 buy was Teva Pharmaceuticals: 1,904,346 shares worth $108M.
- Bridger Management added most to Centene in Q3 2015, an estimated $53.8M increase.
- Bridger Management's biggest Q3 2015 reduction was Marathon Petroleum, cutting an estimated $53.1M.
- Bridger Management fully exited Cardinal Health in Q3 2015, selling an estimated $65.3M.
- Bridger Management's ten largest holdings make up 51% of its $1.47B portfolio in Q3 2015.
- Bridger Management opened 9 new positions and closed 16 in Q3 2015.
- Bridger Management's portfolio value fell 54% quarter-over-quarter to $1.47B.
Based on Bridger Management's 13F filing for Q3 2015, filed 16 Nov 2015.